CD8A and COVID-19: Although recent reports indicated that patients with milder COVID-19 disease had stronger SARS-CoV-2-specific T-cell responses than patients with severe COVID-19 (10, 11), the contribution of SARS-CoV-2-specific CD8+ T-cells and their targeted epitopes for the control of SARS-CoV-2 is still undefined (12).